Literature DB >> 2434599

The human natural anti-Gal IgG. III. The subtlety of immune tolerance in man as demonstrated by crossreactivity between natural anti-Gal and anti-B antibodies.

U Galili, J Buehler, S B Shohet, B A Macher.   

Abstract

A well-defined antigen/antibody system was used to evaluate the effect of immune tolerance on the spectrum of specificities of natural antibodies. The antibody used in this study, anti-Gal, is a naturally occurring, polyclonal IgG that constitutes 1% of the circulating IgG in humans. We have previously shown that anti-Gal, purified from AB sera, specifically interacts with glycosphingolipids bearing a Gal alpha 1----3Gal epitope, but not with the closely related B antigen in which the penultimate galactose of the Gal alpha 1----3Gal epitope is fucosylated Gal alpha 1----3(Fuc alpha 1----2)Gal. This narrow specificity was assumed to be the result of an effective immune tolerance mechanism that prevents the expression of antibody clones that can recognize both the Gal alpha 1----3Gal and the self B epitopes. If the assumption that immune tolerance determines the range of anti-Gal specificity is correct, then anti-Gal from individuals lacking the B antigen (A and O blood types) would be expected to interact with both Gal alpha 1----3Gal and Gal alpha 1----3(Fuc alpha 1----2)Gal epitopes. In this study, anti-Gal from the serum of individuals of various blood types was purified by affinity chromatography on Gal alpha 1----3Gal adsorbent and tested for its reaction with the B antigen. Whereas anti-Gal from AB and B individuals only reacted with Gal alpha 1----3Gal epitopes, anti-Gal from A and O individuals reacted with both Gal alpha 1----3Gal and B epitopes. Furthermore, it was determined that the majority of anti-B reactivity in A and O individuals is in fact anti-Gal antibodies capable of recognizing both Gal alpha 1----3Gal and B epitopes. It can be concluded from these results that immune tolerance accurately controls the spectrum of natural antibody specificities by preventing the production of antibody clones that can interact with self antigens.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2434599      PMCID: PMC2188289          DOI: 10.1084/jem.165.3.693

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  28 in total

1.  Heterogeneity of antibodies to the human blood groups in normal and immune sera.

Authors:  R D OWEN
Journal:  J Immunol       Date:  1954-07       Impact factor: 5.422

Review 2.  The somatic generation of immune recognition.

Authors:  N K Jerne
Journal:  Eur J Immunol       Date:  1971-01       Impact factor: 5.532

3.  The natural anti-alpha-galactosyl IgG on human normal senescent red blood cells.

Authors:  U Galili; I Flechner; A Knyszynski; D Danon; E A Rachmilewitz
Journal:  Br J Haematol       Date:  1986-02       Impact factor: 6.998

4.  Excessive binding of natural anti-alpha-galactosyl immunoglobin G to sickle erythrocytes may contribute to extravascular cell destruction.

Authors:  U Galili; M R Clark; S B Shohet
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

Review 5.  Studies on natural antibodies and autoantibodies.

Authors:  S Avrameas; G Dighiero; P Lymberi; B Guilbert
Journal:  Ann Immunol (Paris)       Date:  1983 Jul-Aug

6.  Lewis blood group fucolipids and their isomers from human and canine intestine.

Authors:  J M McKibbin; W A Spencer; E L Smith; J E Mansson; K A Karlsson; B E Samuelsson; Y T Li; S C Li
Journal:  J Biol Chem       Date:  1982-01-25       Impact factor: 5.157

7.  Blood groups of the mantled howler monkey (Alouatta palliata).

Authors:  J W Froehlich; W W Socha; A S Wiener; J Moor-Jankowski; R W Thorington
Journal:  J Med Primatol       Date:  1977       Impact factor: 0.667

8.  Isolation and structural characterization of human lymphocyte and neutrophil gangliosides.

Authors:  B A Macher; J C Klock; M N Fukuda; M Fukuda
Journal:  J Biol Chem       Date:  1981-02-25       Impact factor: 5.157

9.  A new solvent system for the separation of neutral glycosphingolipids.

Authors:  K Watanabe; Y Arao
Journal:  J Lipid Res       Date:  1981-08       Impact factor: 5.922

10.  SEROLOGICAL STUDIES ON THE BLOOD OF THE PRIMATES : III. DISTRIBUTION OF SEROLOGICAL FACTORS RELATED TO HUMAN ISOAGGLUTINOGENS IN THE BLOOD OF LOWER MONKEYS.

Authors:  K Landsteiner; C P Miller
Journal:  J Exp Med       Date:  1925-11-30       Impact factor: 14.307

View more
  45 in total

1.  Is there a correlation between anti-pig antibody levels in humans and geographic location during childhood?

Authors:  Goutham Kumar; Vikas Satyananda; Jason Fang; Hao Zhou; Minoru Fujita; Burcin Ekser; Cassandra Long; Eefje Dons; Qing Sun; David Ayares; Hidetaka Hara; David K C Cooper
Journal:  Transplantation       Date:  2013-08-27       Impact factor: 4.939

2.  Antibodies to mouse laminin in patients with systemic sclerosis (scleroderma) recognize galactosyl (alpha 1-3)-galactose epitopes.

Authors:  A Gabrielli; M Candela; A M Ricciatti; M L Caniglia; J Wieslander
Journal:  Clin Exp Immunol       Date:  1991-12       Impact factor: 4.330

3.  Simple radioimmunological assay of anti-alpha-galactosyl antibody (anti-Gal): application to autoimmune thyroid diseases and thyroid-associated ophthalmopathy.

Authors:  R J Winand; J Winand-Devigne; C Cox; C Caulier; M Meurisse
Journal:  J Endocrinol Invest       Date:  1995-11       Impact factor: 4.256

4.  Investigation into the α-Gal Syndrome: Characteristics of 261 Children and Adults Reporting Red Meat Allergy.

Authors:  Jeffrey M Wilson; Alexander J Schuyler; Lisa Workman; Monica Gupta; Hayley R James; Jonathon Posthumus; Emily C McGowan; Scott P Commins; Thomas A E Platts-Mills
Journal:  J Allergy Clin Immunol Pract       Date:  2019-03-30

5.  Serological activity against galactosyl-alpha(1-3)galactose in sera from patients with several kinetoplastida infections.

Authors:  J L Avila; M Rojas; H Towbin
Journal:  J Clin Microbiol       Date:  1988-01       Impact factor: 5.948

Review 6.  Bridging innate and adaptive antitumor immunity targeting glycans.

Authors:  Anastas Pashov; Bejatolah Monzavi-Karbassi; Gajendra P S Raghava; Thomas Kieber-Emmons
Journal:  J Biomed Biotechnol       Date:  2010-06-15

7.  Anti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1-3)Gal epitopes.

Authors:  M S Sandrin; H A Vaughan; P L Dabkowski; I F McKenzie
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

8.  Monoclonal antibodies that recognize the trisaccharide epitope Gal alpha 1-3Gal beta 1-4GlcNAc present on Ehrlich tumor cell membrane glycoproteins.

Authors:  M Takagaki; R N Knibbs; J Roth; I J Goldstein
Journal:  Histochemistry       Date:  1993-08

Review 9.  Evolution and pathophysiology of the human natural anti-alpha-galactosyl IgG (anti-Gal) antibody.

Authors:  U Galili
Journal:  Springer Semin Immunopathol       Date:  1993

10.  Anti-alpha-galactosyl immunoglobulin A (IgA), IgG, and IgM in human secretions.

Authors:  R M Hamadeh; U Galili; P Zhou; J M Griffiss
Journal:  Clin Diagn Lab Immunol       Date:  1995-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.